Search

Filters

Clear Filters
9:45 AM - 9:50 AM ET

1246 - Investigating the Role and Mechanisms of Disulfidptosis in Radiotherapy
Speaker: Sun, Yajie, MD - Union Hospital Cancer Center, Tongji Medical College, HUST, Wuhan, Hubei
9:15 AM - 9:20 AM ET

1247 - Integrating Clinical and PET Radiomics Features for Pre-Therapy Cardiac Risk Prediction
Speaker: Panchal, Devanshu, PhD - Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA
9:20 AM - 9:25 AM ET

1248 - External Validation and Development of Radiomics Models for Radiation Pneumonitis after Chemoradio-Immunotherapy in Locally Advanced NSCLC
Speaker: Ebrahimpour, Leyla, PhD - Memorial Sloan Kettering Cancer Center, Middletown Township, NJ
9:25 AM - 9:30 AM ET

1249 - Predicting Late Genitourinary Toxicity after MR-Guided Prostate Stereotactic Radiation Therapy (SBRT) through Integrating Fractional Dosimetry
Speaker: Qi, Xiangrong, PhD - Dept. of Radiation Oncology, Los Angeles, CA
3:40 PM - 3:50 PM ET

125 - Phase I Trial with Expansion Cohort of DNA-PK Inhibitor Peposertib and Intensity Modulated Radiation Treatment (IMRT) in Cisplatin-Ineligible Patients with Stage 3-4 Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Speaker: Samuels, Michael, MD - Banner MD Anderson Cancer Center, Gilbert, AZ
9:30 AM - 9:35 AM ET

1250 - Mid-Treatment CT Mean Density, Volume and Mass Changes as Early Response Biomarkers in Head and Neck Cancer Radiotherapy Using AI-Based Deformable Image Registration
Speaker: Nayak, Lopamudra, PhD - Memorial Sloan Kettering Cancer Center, New York, NY
9:35 AM - 9:40 AM ET

1251 - Interpretable Modeling of Dysphagia Risk after Head and Neck Re-irradiation
Speaker: Wang, Kai, PhD - University of Colorado Anschutz Medical Campus, Aurora, CO
9:40 AM - 9:45 AM ET

1252 - Predictors for Abdominal Acute Toxicity and Acute Care Utilization Following Liver EBRT
Speaker: Lavrova, Elizaveta, MD - UNC Health, Chapel Hill, NC
10:50 AM - 10:55 AM ET

1253 - Impact of Early vs. Delayed All-Site Radiotherapy on Clinical Outcomes in High Gleason Score Metastatic Hormone-Sensitive Prostate Cancer: Results from a Long-Term Study
Speaker: Chen, Huizhu, MD - Peking University First Hospital, Beijing, Beijing
10:55 AM - 11:00 AM ET

1254 - Adjuvant Docetaxel Following Radiotherapy Plus Long-Term ADT for Grade Group 5 Non-Metastatic Prostate Cancer: A Prospective, Comparative Cohort Study
Speaker: Ma, Mingwei, MD - Peking University First Hospital, Beijing, Beijing
11:00 AM - 11:05 AM ET

1255 - Optimizing Postoperative Radiotherapy Target Volumes in Prostate Cancer Based on PSMA PET Recurrence Mapping
Speaker: Zhang, Huan, MD, MS - Peking University First Hospital, Beijing, Beijing
11:05 AM - 11:10 AM ET

1256 - Elective Pelvic Nodal Radiation in Prostate Cancer with and without Mesorectal or Extra-Pelvic Disease
Speaker: Dodge, Jade, MS, BS - Drexel University College of Medicine, Philadelphia, PA